Black Diamond Therapeutics, Inc. (BDTX) (CIK 0001701541) CORRESP

Black Diamond Therapeutics, Inc. (BDTX) (CIK 0001701541) → SEC staff · filed 2025-12-01 · ticker BDTX · SIC 2836 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001104659-25-117310
Form
CORRESP
Filer
Black Diamond Therapeutics, Inc. (BDTX) (CIK 0001701541)
CIK
0001701541
Ticker
BDTX
Filed
2025-12-01
SIC industry
2836
HQ
Cambridge, MA

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1701541/000110465925117310/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗